Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.92 USD | -2.78% | -6.20% | +0.66% |
May. 06 | Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000 | MT |
May. 06 | Celldex Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 2.71M | Sales 2025 * | 2.66M | Capitalization | 2.63B |
---|---|---|---|---|---|
Net income 2024 * | -153M | Net income 2025 * | -196M | EV / Sales 2024 * | 969 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 990 x |
P/E ratio 2024 * |
-17.2
x | P/E ratio 2025 * |
-13.9
x | Employees | 160 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.66% |
Latest transcript on Celldex Therapeutics, Inc.
1 day | -2.78% | ||
1 week | -6.20% | ||
Current month | +6.68% | ||
1 month | +1.71% | ||
3 months | +6.20% | ||
6 months | +48.18% | ||
Current year | +0.66% |
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 82-12-31 |
Anthony Marucci
FOU | Founder | 62 | 82-12-31 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 09-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 08-02-29 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 22-06-15 |
Harry Penner
BRD | Director/Board Member | 78 | 96-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.02% | 0 M€ | +9.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 39.92 | -2.78% | 504,888 |
24-05-09 | 41.06 | -0.36% | 445,535 |
24-05-08 | 41.21 | -2.37% | 397,280 |
24-05-07 | 42.21 | +1.34% | 911,674 |
24-05-06 | 41.65 | -2.14% | 548,617 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.66% | 2.63B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CLDX Stock